Intracranial atherosclerotic disease associated with moyamoya collateral formation: Histopathological findings - Case report

Journal of Neurosurgery

Volumn 118, Issue 5, 2013, Pages 1030-1034

  Jiang, Thomas ^a   Perry, Arie ^b   Dacey, Ralph G ^b   Zipfel, Gregory J ^b   Derdeyn, Colin P ^a,b  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Atherosclerosis; Histopathological study; Lenticulostriate artery; Moyamoya disease; Stroke; Vascular disorders; Vasculopathy

Indexed keywords

ADULT; ARTICLE; BRAIN ATHEROSCLEROSIS; CASE REPORT; DISEASE ASSOCIATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IDIOPATHIC DISEASE; MALE; MOYAMOYA DISEASE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL;

EID: 84877767035     PISSN: 00223085     EISSN: 19330693     Source Type: Journal    
DOI: 10.3171/2013.1.JNS12565     Document Type: Article

References (26)

1. Ahmadi J, Keane JR, McCormick GS, Fallis RJ, Miller CA: Ischemic chiasmal syndrome and hypopituitarism associated with progressive cerebrovascular occlusive disease. AJNR Am J Neuroradiol 5:367-372, 1984 (Pubitemid 14069319)
2. Ashley WW Jr, Zipfel GJ, Moran CJ, Zheng J, Derdeyn CP: Moyamoya phenomenon secondary to intracranial atherosclerotic disease: diagnosis by 3T magnetic resonance imaging. J Neuroimaging 19:381-384, 2009
3. Baba T, Houkin K, Kuroda S: Novel epidemiological features of moyamoya disease. J Neurol Neurosurg Psychiatry 79:900-904, 2008
4. Bruno A, Adams HP Jr, Biller J, Rezai K, Cornell S, Aschenbrener CA: Cerebral infarction due to moyamoya disease in young adults. Stroke 19:826-833, 1988
5. Chiu D, Shedden P, Bratina P, Grotta JC: Clinical features of moyamoya disease in the United States. Stroke 29:1347-1351, 1998 (Pubitemid 28300068)
6. Cloft HJ, Kallmes DF, Snider R, Jensen ME: Idiopathic supraclinoid and internal carotid bifurcation steno-occlusive disease in young American adults. Neuroradiology 41:772-776, 1999 (Pubitemid 30011924)
7. Fukui M: Guidelines for the diagnosis and treatment of spontaneous occlusion of the circle of Willis ('moyamoya' disease). Clin Neurol Neurosurg 99:S238-S240, 1997
8. Fukui M, Kono S, Sueishi K, Ikezaki K: Moyamoya disease. Neuropathology 20 Suppl:S61-S64, 2000
9. Hallemeier CL, Rich KM, Grubb RL Jr, Chicoine MR, Moran CJ, Cross DT III, et al: Clinical features and outcome in North American adults with moyamoya phenomenon. Stroke 37:1490-1496, 2006 (Pubitemid 44305731)
10. Hoshimaru M, Takahashi JA, Kikuchi H, Nagata I, Hatanaka M: Possible roles of basic fibroblast growth factor in the pathogenesis of moyamoya disease: an immunohistochemical study. J Neurosurg 75:267-270, 1991
11. Ikezaki K, Han DH, Kawano T, Kinukawa N, Fukui M: A clinical comparison of definite moyamoya disease between South Korea and Japan. Stroke 28:2513-2517, 1997 (Pubitemid 28007660)
12. Ikezaki K, Inamura T, Kawano T, Fukui M: Clinical features of probable moyamoya disease in Japan. Clin Neurol Neurosurg 99 (Suppl 2):S173-S177, 1997 (Pubitemid 27489089)
13. Kono S, Oka K, Sueishi K: Histopathologic and morphometric studies of leptomeningeal vessels in moyamoya disease. Stroke 21:1044-1050, 1990 (Pubitemid 20218169)
14. Kraemer M, Heienbrok W, Berlit P: Moyamoya disease in Europeans. Stroke 39:3193-3200, 2008
15. Mastri AR, Silverstein PM, Gold L, Eselius EP: Multiple progressive intracranial arterial occlusions. Stroke 4:380-386, 1973
16. Masuda J, Ogata J, Yutani C: Smooth muscle cell proliferation and localization of macrophages and T cells in the occlusive intracranial major arteries in moyamoya disease. Stroke 24:1960-1967, 1993 (Pubitemid 23352730)
17. Nanba R, Kuroda S, Ishikawa T, Houkin K, Iwasaki Y: Increased expression of hepatocyte growth factor in cerebrospinal fluid and intracranial artery in moyamoya disease. Stroke 35:2837-2842, 2004 (Pubitemid 39565180)
18. Oka K, Yamashita M, Sadoshima S, Tanaka K: Cerebral haemorrhage in Moyamoya disease at autopsy. Virchows Arch A Pathol Anat Histol 392:247-261, 1981 (Pubitemid 11039285)
19. Peerless SJ: Risk factors of moyamoya disease in Canada and the USA. Clin Neurol Neurosurg 99 (Suppl 2):S45-S48, 1997
20. Pilgreen KL, Lum GB, Hamilton WJ, Nelson GA: Medical pathology conference. Altered level of consciousness and right hemiparesis in a 24-year-old woman. Ala J Med Sci 23:296-302, 1986
21. Rao M, Zhang H, Liu Q, Zhang S, Hu L, Deng F: Clinical and experimental pathology of Moyamoya disease. Chin Med J (Engl) 116:1845-1849, 2003 (Pubitemid 38159883)
22. Scott RM, Smith ER: Moyamoya disease and moyamoya syndrome. N Engl J Med 360:1226-1237, 2009
23. Takagi Y, Kikuta K, Nozaki K, Hashimoto N: Histological features of middle cerebral arteries from patients treated for Moyamoya disease. Neurol Med Chir (Tokyo) 47:1-4, 2007 (Pubitemid 46168933)
24. Wakai K, Tamakoshi A, Ikezaki K, Fukui M, Kawamura T, Aoki R, et al: Epidemiological features of moyamoya disease in Japan: findings from a nationwide survey. Clin Neurol Neurosurg 99 (Suppl 2):S1-S5, 1997 (Pubitemid 27489053)
25. Yamashita M, Oka K, Tanaka K: Histopathology of the brain vascular network in moyamoya disease. Stroke 14:50-58, 1983 (Pubitemid 13174997)
26. Yoshimoto T, Houkin K, Takahashi A, Abe H: Angiogenic factors in moyamoya disease. Stroke 27:2160-2165, 1996 (Pubitemid 26427185)